期刊文献+

干细胞技术结合新型可降解材料进行腰椎融合的临床研究 被引量:6

Clinical study of lumbar fusion by hybrid construct of stem cells technique and biodegradable material
原文传递
导出
摘要 目的探索富集骨髓干细胞技术进行腰椎融合治疗脊柱疾病的疗效。方法 腰椎退行性疾患患者56例,根据行下腰椎后路融合手术中植骨融合材料的不同,分为富集骨髓干细胞快速复合多孔β-磷酸三钙(β-TCP)复合材料组(复合材料组,n=30)和自体髂骨植骨组(自体骨组,n=26)。对复合材料组富集前后骨髓体积、有核细胞(NCs)和碱性磷酸酶染色阳性的细胞集落(CFUs/ALP^+)计数,分析富集效率;结合随访、影像学检查和Oswestry功能评分等综合评定疗效。结果复合材料组术中平均抽取骨髓血(249±31)ml,富集技术平均回收(43±11)ml,NCs由(15.9±3.3)×10^6/ml浓缩至(44.1±10.8)×10^6/ml,富集后CFUs/ALP^+数量由(118±86)/ml浓缩至(486±305)/ml。临床随访(26.3±7.5)个月。两组中患者的年龄、性别、病种分布及融合节段无显著差异,复合材料组与自体骨组融合率分别为93.3%和96.2%(P〉0.05)。两组手术时间的差异也无统计学意义(P〉0.05)。复合材料组术中患者的总出血量高于自体骨组(P〈0.01),但术中自体血回输可以将接近1/2的术中出血回输给患者。复合材料组术后骨髓采集部无血肿和慢性疼痛,伤口渗出或局部肿胀4例,均自行愈合;而自体骨组术后髂骨采集部血肿(15.4%)和慢性疼痛(26.9%),无伤口渗出的情况。两组间Oswestry功能评分的差异无统计学意义(P〉0.05)。结论富集骨髓干细胞技术可在术中一期应用,提高骨髓MSCs的浓度,安全、快速。富集骨髓干细胞快速复合多孔β-磷酸三钙后,可作为腰椎后外侧融合的植骨替代品。 Objective To explorer the effectiveness of enriched bone marrow stem cells technique for lumbar fusion. Methods With the randomization and control principles, 2 graft materials [ Enrichment bone marrow mesenchymal stem cells hybriding with β-tri calcium phosphate (composite graft group), autologous iliac crest bone graft ( autograft group) ] were compared in posterior lumbar fusion procedures. 56 patients with degenerative disc disease, lumbar instability or spinal stenosis, were included. The volume of cells suspension in pre- and post-enrichment and the number of nucleated cells (NCs) were identified. The number of osteoprogenitor cells was estimated by counting the colony-forming units which express alkaline phosphatase ( CFUs/ALP^± ). Then the efficiency of the enrichment was evaluated. Clinical follow-up with roentgenogram and Oswestry scale scores was performed for outcome evaluatiorL Results ( 249 ± 31 ) ml bone marrow per patient from bilateral iliac crests was aspirated peri-operatively. About ( 43 ± 11 ) ml enriched bone marrow was collected. The number of NCs was concentrated from ( 15.9 ±3.3) x 106/ml to (44. 1 ±10. 8) × 10^6/ml, CFUs/ALP^+ was significantly increased from (118 ±86)/ml to(486 ±305)/ml. The follow-up was about (26. 3±7.5) months. There was no significant differences in age, gender, disease and fusion segments between the two groups. The fusion rate was 93. 3% and 96. 2% for composite graft group and autograft group, respectively (x^2 = 0. 2146, P = 0. 6432 ). There was no difference in operation time between the two group ( t = 0. 5243, P = 0. 6022 ), but blood loss in composite graft group was more than that in autograft group ( t = 6. 4664, P 〈 0. 01 ). Cell salvage for auto-transfusion could transfuse back half of the blood loss during operation. No hematoma or chronic soreness in the bone marrow donor sites of composite graft group occurred, but a little exudation or moderate swelling in the wound happened in 4 cases which disapeared under medical treatment. Meanwhile, 15.4% patients had hematoma in the iliac bone donor site and 26. 9% patients had chronic soreness, but no case had wound problem in autograft group. As for Oswestry scale scores, there was no significant difference between the two groups. Conclusions The enrichment technique of autologous bone marrow stem cells can greatly increase the concentration of MSCs. It is a rapid and safe method used peri-operatively. The composite material of enriched MSCs and porous β- TCP is a good bone substitute in posterior spinal fusion.
出处 《中华外科杂志》 CAS CSCD 北大核心 2008年第7期493-496,共4页 Chinese Journal of Surgery
基金 上海市科委国际合作重点课题资助项目(045407008) 上海市科委课题资助项目(054119651)
关键词 干细胞移植 脊柱融合术 生物相容性材料 Stem cell transplantation Spinal fusion Biocompatible materials
  • 相关文献

参考文献11

  • 1Boden SD. Overview of the biology of lumbar spine fusion and principles for seleeting a bone graft substitute. Spine, 2002, 27 ( 16Suppl 1 ) :26-31.
  • 2Banwart JC, Asher MA, Hassanein RS. Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine, 1995, 20 : 1055-1060.
  • 3陆骅,汤亭亭,戴克戎.不同材料对人骨髓间充质干细胞增殖的影响[J].临床骨科杂志,2001,4(2):81-83. 被引量:10
  • 4Brantigan JW. Pseudarthrosis rate after allograft posterior lumbar interbody fusion with pedicle screw and plate fixation. Spine, 1994, 19 : 1271-1279.
  • 5Dai KR, Xu XL, Tang TT, et al. Repairing of goat tibial bone defects with BMP-2 gone-modified tissue-engineered bone. Calcified Tissue Int, 2005, 77:55-61.
  • 6张蒲,干耀恺,李华,郝永强,王友,孙月华,朱振安,戴尅戎.富集骨髓干细胞结合β磷酸三钙在脊柱融合的临床应用[J].临床骨科杂志,2006,9(1):1-4. 被引量:8
  • 7干耀恺,戴尅戎,张蒲,汤亭亭,郝永强,唐坚,史定伟,王友,孙月华,朱振安.应用富集骨髓干细胞技术治疗骨缺损[J].中华骨科杂志,2006,26(11):721-727. 被引量:31
  • 8周健,戴克戎,汤亭亭.复合骨髓间充质干细胞生物陶瓷修复兔松质骨缺损[J].临床骨科杂志,2003,6(2):97-102. 被引量:12
  • 9Hemigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res, 2002 (405) : 14-23.
  • 10Lu JX, Gallur A, Flautre B, et al. Comparative study of tissue reactions to calcium phosphate ceramics among cancellous, conical, and medullar bone sites in rabbits. J Biomed Mater Res, 1998, 42 : 357-367.

二级参考文献42

  • 1涂强,徐国洲,钟润泉,王少华.骨髓间充质干细胞在骨组织工程中的研究进展[J].临床骨科杂志,2005,8(1):92-94. 被引量:3
  • 2[1]Goshima J, Goldberg VM, Caplan AI. The osteogenic potential of culture-expanded rat marrow mesenchymal cells assayed in vivo in calcium phosphate ceramic blocks[J]. Clin Orthop, 1991; (262): 298~311
  • 3[2]Bruder SP, Kurth AA, Shea M et al. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells[J].J Orthop Res,1998; 16(2): 155~162
  • 4[3]Bruder SP, Kraus KH, Goldberg VM et al. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects[J]. J Bone Joint Surg Am,1998; 80(7): 985~996
  • 5[4]Mejdahl S, Hansen CA, Skjot H. Human bone bank allografts stimulate bone resorption and inhibit proliferation in cultures of human osteoblast-like cells[J]. Acta Orthop Scand, 1998; 69(1): 63~68
  • 6Lu JX, Lu Gallur A, Flaufre B et al. Comparative study of tissue reactions to calcium phosphate ceramics among cancellous cortical,and medullar bone sites in rabbits [ J]. J Biomed Mater Res, 1998 ;42(3) :357 -367.
  • 7Cypher TJ, Grossman JP. Biological principles of bone graft healing[J]. J Foot Ankle Surg, 1996;35(5): 413 -417.
  • 8Dennis JE, Caplan A1, Differentiation potential of conditionally immortalized mesenchymal progenitor cell from adult marrow of a H-2Kb-tsA58 transgenic mouse [ J ]. J Cell Physiol, 1996 ; 167 ( 3 ) :523-538.
  • 9Ohgushi H, Dohi Y, Katuda T et al. In vitro bone formation by rat marrow cell culture[ J ]. J Biomed Mater Res, 1996 ;32 (3) :333 -340.
  • 10Kadiyala S, Young RG, Thiede MA et al. Culture expanded canine mesenchymal stern cells possess osteochondrogenic potential in vivo and in vitro[J]. Cell Transpl, 1997;6(2) :125 -134.

共引文献53

同被引文献61

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部